Protocol Ledger

NCT06047171 · Phase II · RECRUITING

Rescue of Nephrons With ALE.F02 (RENAL-F02)

Interventional Phase II clinical trial protocol NCT06047171 sponsored by Alentis Therapeutics AG in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-09-07 Enrollment: 80 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06047171
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)80 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06047171
Protocol FieldVerified Registry Value
NCT IdentifierNCT06047171
Consolidated Lead SponsorAlentis Therapeutics AG
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment80 participants (ESTIMATED)
Registered Start Date2023-09-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06047171
Hospital Research SiteLocationSite Profile
Vseobecna fakultni nemocnice v PrazePrague, CzechiaOpen Hospital Dossier ->
Aalborg University HospitalAalborg, DenmarkOpen Hospital Dossier ->
Aarhus University HospitalAarhus, DenmarkOpen Hospital Dossier ->
RigshospitaletCopenhagen, DenmarkOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI